About BioMed Central
BioMed Central is a company based in London (United Kingdom) founded in 2000 by Ayanna Anene was acquired by Springer in October 2008. BioMed Central offers products and services including Open Access Journals and Data Sharing Services.
- Headquarter London, United Kingdom
- Founders Ayanna Anene
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomed Central Ltd
-
Annual Revenue
$119.4 K (USD)15as on Dec 31, 2022
-
Net Profit
$37.33 K (USD)0as on Dec 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Fortress Investment
& 3 more
-
Employee Count
Not available
-
Acquired by
Springer
(Oct 07, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioMed Central
BioMed Central offers a comprehensive portfolio of products and services, including Open Access Journals and Data Sharing Services.
Research in biology and medicine is published through these journals
Data sharing and open access practices are supported to advance research in health sciences
People of BioMed Central
Unlock access to complete
Unlock access to complete
Funding Insights of BioMed Central
Investors in BioMed Central
BioMed Central has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Fortress Investment, HHS and Springer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of credit, private equity, and capital investment services
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for BioMed Central
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioMed Central
Investment portfolio details for BioMed Central
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioMed Central
Detailed financials for BioMed Central
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomed Central Comparisons
Peer comparison for BioMed Central
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioMed Central
Detailed competitors of BioMed Central
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomed Central
Complete news archive for BioMed Central
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioMed Central
BioMed Central was founded in 2000 and raised its 1st funding round 9 years after it was founded.
BioMed Central is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Etienne Boue is the current CEO of BioMed Central.
Annual revenue of BioMed Central is $119.4K as on Dec 31, 2022.
BioMed Central was founded in 2000 and is headquartered in London, United Kingdom. Operations focus on open-access publishing within the scientific sector, particularly biology, health sciences, and medicine. A portfolio of journals is maintained to enable researchers to share work through peer-reviewed processes. Author support is provided, including advice on funding and data sharing. Transparency in publishing and open data practices are emphasized across activities.
BioMed Central offers Open Access Journals and Data Sharing Services.
BioMed Central has 4 investors. Key investors include Fortress Investment, HHS, Springer, and European Union.